Skip to content

IPHA

Innate Pharma SA

NASDAQ · Healthcare · Biotechnology · FR

$1.46
+2.10%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
2.17x
P/S forward
28.81x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
-3.59x
Price / sales
134.12x
Price / cash flow
-3.25x

Enterprise value

Enterprise value
$173.5M
EV / sales
142.70x
EV / EBITDA
-2.98x
EV / EBIT
-3.10x
Market cap
$163.1M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026